GASTRORETENTIVE FLOATING TECHNOLOGY FOR ERADICATION OF HELICOBACTER PYLORI: AN INSIGHT VIEW release_peabwrlsyjgu5dqnhuw6dnyqjq

by RAKESH PAHWA, BIGUL YOGESHVER BHARDWAJ, ARCHANA SHARMA, MONA PIPLANI, MANISH KUMAR

Published in International Journal of Applied Pharmaceutics by Innovare Academic Sciences Pvt Ltd.

2021   p5-10

Abstract

Helicobacter pylori is a virulent human pathogen infecting about 50% of the population worldwide. Being a leading cause of gastric ulcer, duodenal ulcer, gastritis, dyspepsia, gastric tumorigenesis etc., this organism has been the focus of concerted study to establish uncertainty of its genetics, immunopathogenesis and cell biology. Scientists have tried to effectively eradicate this pathogen from the gastrointestinal tract in various manners. Inquest of this venture, gastroretentive drug delivery systems including floating dosage forms have emerged as a boon and offer significantly improved therapeutic effects of different antimicrobial drugs. This article presents an evocative review of the structural features, epidemiological evidences and various pharmacotherapeutics vistas. In addition, various novel gastroretentive dosage forms developed so far to combat Helicobacter pylori infection are also discussed. Comprehensive literature review has been performed for this manuscript by utilizing relevant databases like PubMed, SCOPUS, Web of Science, Science Direct, Google Scholar etc., from 1997 up to the year 2020.
In application/xml+jats format

Archived Files and Locations

application/pdf  406.0 kB
file_55qsctpbizhk3l4k3chwi3vms4
innovareacademics.in (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2021-05-07
Journal Metadata
Not in DOAJ
Not in Keepers Registry
ISSN-L:  0975-7058
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 647f5e9b-ab48-43ce-bd4b-28615b02cb59
API URL: JSON